Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

2

Archives Medical Review Journal. 2011; 20(4): 270-277


New Inhalation Agents and Hepatotoxicity

Yasemin Güneş.

Abstract
Hepatotoxicity with halothane inhalation has been studied extensively. Risk factors include obesity, female sex, a history of drug allergies, and multiple exposures to anesthetic agents. Anesthetic agents including halothane, enflurane, isoflurane, and desflurane can produce metabolic hepatocellular injury in humans to a variable extent. Sevoflurane is expected to be less hepatotoxic than halothane because it is metabolized less, and the main metabolite is different and rapidly glucuronated. Cross-sensitization between halothane and other volatile agents has been previously reported with isoflurane, enflurane, and desflurane. In this article, the topic of postoperative hepatic dysfunction associated with new inhalation agents is revisited.

Key words: Hepatotoxicity, inhalation agents



Share this Article


Advertisement
Journal of Interdisciplinary Histopathology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons